HomeAI · summaries
Storia in 9 fonti
A personalized vaccine for melanoma cut the risk of cancer returning after five years
If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
npr.org
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
- ·
nbcnews.com
A personalized vaccine for melanoma cut the risk of cancer returning after five years
If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.
- ·
dailymail.com
Cancer vaccine cuts risk of deadly skin cancer returning by half in
Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their disease returning by almost half.
- ·
ansa.it
Melanoma, a 5 anni vivo il 92% dei pazienti trattato con il vaccino personalizzato - Focus Tumore news - Ansa.it
Dal congresso mondiale di oncologia ASCO in corso a Chicago arriva una importante conferma sull'efficacia del vaccino a mRna contro il melanoma, la cui sperimentazione è iniziata…
- ·
tg24.sky.it
Melanoma, a 5 anni vivo il 92% trattato con vaccino personalizzato
Leggi su Sky TG24 l'articolo Melanoma, a 5 anni vivo il 92% trattato con vaccino personalizzato
- ·
independent.co.uk
Breakthrough melanoma vaccine would slash risk of the deadly cancer returning
An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year
- ·
forbes.com
New Study Shows How mRNA Vaccines Could Transform Cancer Treatment
A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients
- ·
liberoquotidiano.it
Melanoma, il vaccino ad hoc: crolla del 49% il rischio recidiva | Libero Quotidiano.it
Un vaccino, combinato all'immunoterapia, ha dimostrato una clamorosa efficacia nell'evitare il rischio di una recidiva di un melanom...
- ·
medpagetoday.com
Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years
Adjuvant approach will need confirmation from ongoing phase III trial, says expert